Involving patients in clinical trial development
Patient involvement … making it happen

A recording of the webinar held on Thursday 16 September 2021

Be prepared as you will need to involve patients in the design and development of your clinical trials.

Patient involvement as raised in E8(R1) and its likely requirement in E6(R3).

The ICH Reflection Paper and EMA published comments from stakeholders.
Forthcoming regulatory requirements and regulator fact finding.

How do you involve patients? Sharing current practice.

Taking patient involvement beyond lip service.

What does it mean in practical terms?

What do you need to do to make it happen?

Brought to you by Professor David Hutchinson (Brookwood) and Mary Lynne Van Poelgeest-Pomfret.

Lynne is a long-standing international patient advocate promoting the rights of patients at both national and international levels. Lynne is President of the World Federation for Incontinent Patients ... dedicated to enhancing the rights of patients suffering from incontinence. She is also Vice Chair of the European Federation for Good Clinical Practice (EFGCP).